title: New glutamatergic target for alcohol and substance use disorder medications.
authors.affiliation: Nathan Kline Institute, Neurobehavioral Genetics, New York University School of Medicine, Psychiatry, New York, USA, VADASZ@NKI.RFMH.ORG.
authors.forename: Csaba
authors.initials: C
authors.lastname: Vadasz
authors.forename: Mariko
authors.initials: M
authors.lastname: Saito
mesh_terms: D019973:Alcohol-Related Disorders / Q000188:drug therapy*; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D058990:Molecular Targeted Therapy; D017470:Receptors, Glutamate / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy*; D009435:Synaptic Transmission / Q000187:drug effects*
chemical_list: D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D017470:Receptors, Glutamate; D018698:Glutamic Acid